Drug firm Hetero on Wednesday said it has launched generic oral antiviral drug Favipiravir used for the treatment of patients with mild to moderate COVID-19, in India under the brand name 'Favivir' at Rs 59 per tablet. The company has been granted the manufacturing and marketing approval for Favipiravir from the Drug Controller General of India (DCGI), Hetero said in a statement.To Contact Insurance and Investment Expert
Thanks for reading. Please Share, Comment, Like the post And Follow, Subscribe Insurance and Investment News
from Source
Hetero launches generic COVID-19 drug at Rs 59 per table
![Hetero launches generic COVID-19 drug at Rs 59 per table]()
Reviewed by Insurance Advisor
on
July 29, 2020
Rating:
No comments: